TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
RevitaLash Cosmetics says its bestselling RevitaLash Advanced lash serum sold at a rate equivalent to one tube every 30 seconds in 2025. The company calculated the figure by dividing annual sales by the seconds in a year; the source does not provide the underlying sales total or independent verification.
RevitaLash Cosmetics says one tube of its RevitaLash Advanced lash serum sold every 30 seconds, a rate calculated from the product’s 2025 sales. The figure highlights the company’s best-selling product, but the company’s material does not state the total number of tubes sold or identify an independent audit of the calculation.
The company’s stated calculation divides 2025 RevitaLash Advanced sales by the number of seconds in a year. It is a sales-rate description, not a claim that purchases were evenly distributed throughout the year. The source does not disclose the revenue or unit-sales data used to produce it, so readers cannot independently reproduce the figure from the information provided.
RevitaLash Advanced is the brand’s flagship lash serum. The company says its wider product range also includes RevitaLash Advanced Sensitive, a product marketed for sensitive eyes; Advanced Pro, sold through the professional aesthetics channel; and Peptide Complex+, described as a lash serum made without prostaglandins. These are company product descriptions, not independent assessments of comparative performance or suitability.
RevitaLash also reports that Advanced has received more than 30 industry awards and accumulated 31,000 five-star reviews globally as of Sept. 30, 2025. Those figures come from the company’s supplied material. Its consumer-study summary says 94% of participants reported improved lash appearance and nourished, healthier-looking lashes after eight weeks; the study involved 157 participants. The account does not provide enough methodological detail to assess the result independently.
What the Sales Rate Tells Consumers
The claim offers a compact indicator of the product’s reported commercial scale, as the beauty market has expanded around lash and brow serums. But a rate based on annual sales is not a measure of clinical effectiveness, consumer satisfaction across all purchasers, or repeat buying. Without the underlying unit total and a stated comparison with earlier years or competing products, it also cannot establish how quickly sales are growing or how the brand ranks in the market.
For shoppers, the distinction matters because the marketing figure may be read as social proof. Sales volume and customer reviews can indicate popularity, but they do not establish that a cosmetic product will produce the same result for each person. The source describes RevitaLash Advanced as a cosmetic formula intended to condition lashes; it does not provide evidence that it treats hair loss or any medical condition. People with eye conditions or concerns about ingredients can seek advice from an eye-care professional before using products near the eyes.
The brand’s origin story and charitable work form part of its public identity, but they are separate from the evidence behind the sales statistic. RevitaLash says it has contributed more than $14 million since 2008 to cancer research, patient care and education. That is a company-reported cumulative figure, and the source does not give a breakdown by recipient or year.
Products Worth Considering
OMRON Complete 2-in-1 Upper Arm Blood Pressure Monitor with EKG
Garmin Venu 3S GPS Smartwatch with AMOLED Display, Soft Gold and French Gray Silicone Band
Oral-B iO5 Rechargeable Electric Toothbrush with 5 Cleaning Modes and Travel Case, White
As an affiliate, we earn on qualifying purchases.
From a Personal Formula to a Brand
According to the company’s account, ophthalmologist Dr. Michael Brinkenhoff developed the original serum for his wife, Gayle, while she was facing metastatic breast cancer. The company says changes to the health and appearance of her lashes affected her confidence, and that friends and fellow patients asked to try the formula after noticing her results. The account presents this as the origin of the business; it is not an independent report on the product’s development or effects.
The Brinkenhoffs began distributing samples at industry trade shows and later expanded production. RevitaLash says the lash-serum category was not established when it entered the market in 2006, and it marks 20 years in business with a fundraising goal of “20 Years. $20 Million. One Mission.” The company says the initiative will support its cancer-related philanthropy. Its material names partners including London’s Francis Crick Institute, Future Dreams and The House of Hope in Scotland.
The product line has also changed with consumer preferences, according to the company. The newest item named in the source, Peptide Complex+, is described as a time-release serum formulated without prostaglandins. The source does not specify when it launched, provide comparative product testing, or explain the evidence behind the company’s descriptions of its technologies.
““Safety was paramount – and still is today.””
— Dr. Michael Brinkenhoff, RevitaLash founder, as quoted in the company material
Sales Data Behind the Claim
The source does not disclose the number of tubes sold, the calculation’s underlying records, or whether an outside party verified the sales data. It also does not clarify whether the calculation counts sales to retailers, direct purchases by consumers, or another measure. The wording should therefore be understood as the company’s description of its 2025 sales, not an independently verified count of individual purchases occurring at regular 30-second intervals.
Other claims also have limits in the material provided. The 94% consumer-study result is accompanied by the sample size and eight-week period, but details about recruitment, study design, funding and the questions asked are absent. The review total is described as an aggregate, without further information on how reviews were collected or verified. The source does not supply a market-wide dataset supporting the label of global category leader.
Anniversary Campaign and Product Range
RevitaLash’s announced next step is its “20 Years. $20 Million. One Mission” goal, intended to bring its international community into its cancer-related fundraising. The source does not give a schedule, milestones, or a breakdown of how contributions will be raised and distributed. Further details from the company would help clarify how progress toward the target will be reported.
The brand is also continuing to present a range of lash products for different consumer preferences, including its prostaglandin-free Peptide Complex+ and Advanced Sensitive. No new independent sales figures, product testing results or regulatory developments are included in the material. Any future assessment of the “one tube every 30 seconds” claim would benefit from disclosure of the unit-sales total, calculation period and verification method.
Key Questions
What does “one tube every 30 seconds” mean?
It is a rate RevitaLash calculated from 2025 sales of RevitaLash Advanced by dividing sales by the number of seconds in a year. It does not mean a tube was necessarily purchased at evenly spaced 30-second intervals.
Is the sales figure independently verified?
The source material does not identify an independent audit or provide the underlying sales total. The claim is presented as a company calculation.
What did the reported consumer study find?
RevitaLash says that in an eight-week study of 157 participants, 94% reported improved lash appearance and nourished, healthier-looking lashes. The material does not include enough study-design information to assess the finding independently.
What other lash serums does the company sell?
The company lists Advanced Sensitive, Advanced Pro for the professional aesthetics channel, and Peptide Complex+, which it describes as made without prostaglandins, alongside RevitaLash Advanced.
Does the sales claim prove the serum works for everyone?
No. Sales volume does not establish an individual result or prove a medical benefit. The source describes the product as a cosmetic lash serum; people with eye conditions or concerns about use near the eyes can consult an eye-care professional.
Source: cosmeticsbusiness.com
